The purpose of the Scientific Advisory Board is to advise and undertake the strategies, plans and activities of NHRI as they relate to its scientific affairs, and are consistent with the purpose of the NHRI. Ronald Ross Watson is the Technical Director of the Scientific Advisory Board and arranges for Scientific Advisory Board meetings and the technical activities of the NHRI.
All Scientific Advisory Board members are distinguished scientists with expertise in the various areas needed by the NHRI, except for one member at large who has communications or industry credentials.
Introducing NHRI’s Scientific Advisory Board Members
Ronald Ross Watson, Ph.D.
Dr. Watson, Director of the Scientific Advisory Board, is a Professor of Health Protection Sciences at the University of Arizona and is the panel manager of the USDA team for reviewing grants in active nutritional elements in foods. He initiated and directed the Specialized Alcohol Research Center at the University of Arizona and received awards as a Future Leader by the Nutrition Foundation. He has published over 450 papers in the research areas of effects of dietary nutrients in adults, the elderly, and AIDS patients, ethanol induced immune suppression, beta carotene and cellular immunity, nutrition in cancer prevention, and slowing aging.
Richard Cantrill, Ph.D.
Dr. Cantrill is Technical Director of the American Oil Chemists Society (AOCS).
Edward Farnworth, Ph.D.
Dr. Farnworth is Chief of Science Advice, Food Regulatory Issues, Agriculture and Agri-Food Canada, Editor in Chief of Medicinal Food News, and on the Editorial Board of the Food Science and Technology Bulletin: Functional Foods. He is a past president of the Canadian Society for Nutritional Science. He has presented over 200 research papers and reviews. His research interests include the areas of probiotics and prebiotics, fetal and maternal nutrition, conjugated linoleic acid metabolism, digestion and absorption of bioactive ingredients, and biomarkers for clinical trials.
James J. Gormley
James J. Gormley is the Scientific Advisory Board member-at-large and Secretary of the NHRI. As an award-winning journalist, blogger and published health book author, he assists the Board in publicity. His 21 years of experience in health media and scientific relations include: medical journal editor; editor-in-chief of “Better Nutrition”; scientific and regulatory affairs liaison for Nutrition 21; and editorial director of the “Vitamin Retailer” magazine group. He is VP and senior policy advisor for Citizens for Health, a leading grassroots health advocacy organization.
Russell M. Jaffe, Ph.D., M.D., CCN
Dr. Jaffe is a Fellow, Health Studies Collegium, and Founder of PERQUE LLC, a firm producing items for practitioners. In the past, he has been an official at the National Institutes of Health and Clinical Center in Bethesda, the US Public Health Service, and on the editorial board of The New Physician. For the past four years he has been selected as one of America’s Top Physicians, and selected as International Scientist of the Year in 2003 at Oxford. His published research includes over 400 papers in the areas of clinical and nutritional immunology, toxic minerals, hormones, and chemical disruptors, and autoimmune disease.
Michael Lelah, Ph.D.
Dr. Lelah is the Industry Representative of the Scientific Advisory Board and Technical Director at Now Foods in Bloomingdale, IL. Now Foods is a leading health food firm and a major sponsor of the Scientific Advisory Board. At Now Foods, Dr Lelah supervises a staff of 70 in the areas of Research and Development, Quality Control, Nutritional Services, and External Affairs. His background includes a PhD in Chemical Engineering, and twenty years of industrial experience of as a researcher, engineer, and manager in the food, pharmaceutical, healthcare, and plastics industries.
Patrick Massey, M.D., Ph.D.
Dr. Massey is Medical Director of Complementary and Alternative Medicine for the Alexian Brothers Hospital Network and president of ALT-MED Medical and Physical Therapy Program, Elk Grove Village IL. Dr. Massey is a board certified internist and graduate fellow of the Program in Integrative Medicine at the University of Arizona. He has been a leader in clinical integrative medicine for over 20 years. He lectures nationally on various integrative medicine topics and is a reviewer for several peer reviewed medical journals as well as the American Alzheimer’s Association. He has published in peer reviewed journals in both basic and clinical science.
Richard B. van Breemen, Ph.D.
Dr. Richard van Breemen received his Ph.D. in Pharmacology and Experimental Therapeutics from Johns Hopkins University and B.A. in Chemistry with honors from Oberlin College. He was Editor-in-Chief of Combinatorial Chemistry & High Throughput Screening and is currently on the editorial boards of Biomedical Chromatography and Assay and Drug Development Technologies. He received a University Scholar Faculty Award from the University of Illinois, a 2010 Expert Methods Panel Award from the AOAC International for his work on analytical methods for dietary supplements, and the 2008 Harvey W. Wiley Award from the AOAC International. The research of Dr. van Breemen concerns the discovery and development of natural products as chemoprevention agents and the investigation of botanical dietary supplements as alternatives to traditional estrogen replacement therapy.
Richard L. Sharpee, Ph.D.
Dr. Sharpee is Scientific Research Manager at NOW Health Group, Inc. in Bloomingdale, IL and Director, Program Development NHRI. At NOW Foods, he is responsible for new product development, clinical testing for safety and effectiveness and technical support for all dietary supplement products in both the practitioner line (Protocol for Life Balance) and retail market world-wide. At the NHRI, he is responsible for the development of scientific symposia on scientific evidence on the health benefits and cost-effectiveness of dietary supplements. He received a B.S degree in Bacteriology from the Univ. of Wisconsin, a M.S. in Microbiology and immunology from Miami Univ. and a Ph.D. in Microbiology (Virology) from Univ. of Nebraska. He has over 20 years of broad-based experience in research, innovative industry-first product development, GMP manufacturing and technical market support in the dietary supplement, animal health and pharmaceutical industries. He was named as a “Top 100 innovator” for the development of the world’s first vaccine for feline leukemia, a co-discoverer of rotavirus and the discoverer of coronavirus in cattle.